3'-Azido-3'-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator

Biochemical Pharmacology
M BarileE Quagliariello

Abstract

To gain some insight into the mechanism by which 3'-azido-3'-deoxythymidine (AZT) impairs mitochondrial metabolism, [14C]AZT uptake by rat liver mitochondria (RLM) in vitro was investigated. AZT accumulated in mitochondria in a time-dependent manner and entered the mitochondrial matrix. The rate of AZT uptake into mitochondria showed a hyperbolic dependence on the drug concentration and was inhibited by mersalyl, a thiol reagent that cannot enter mitochondria, thus showing that a membrane protein is involved in AZT transport. Investigation into the capability of AZT to affect certain mitochondrial carriers demonstrated that AZT was able to impair the ADP/ATP translocator, but had no effect on Pi, dicarboxylate, tricarboxylate, or oxodicarboxylate carriers. AZT inhibited ADP/ATP antiport in either mitochondria or mitoplasts in a competitive manner with different sensitivity (Ki values were 18.3 +/- 2.9 and 70.2 +/- 5.8 microM, respectively). Consistent with this were isotopic measurements showing that AZT accumulates in the intermembrane space. AZT does not use ADP/ATP carrier to enter mitochondria, as shown by the failure of both carboxyatractyloside (CAT) to inhibit AZT transport into mitochondria and AZT to induce ATP efflux ...Continue Reading

References

Jan 30, 1977·Archives of Biochemistry and Biophysics·J Meyer
Sep 1, 1975·European Journal of Biochemistry·P FeldhauR H Schirmer
Jan 1, 1979·Methods in Enzymology·F Palmieri, M Klingenberg
Apr 19, 1990·The New England Journal of Medicine·M C DalakasJ L Griffin
Aug 1, 1990·Archives of Biochemistry and Biophysics·M BarileE Quagliariello
Oct 4, 1990·The New England Journal of Medicine·R GoldH Reichmann
Dec 15, 1986·Biochemical and Biophysical Research Communications·A AtlanteC Salet
Oct 31, 1988·Biochemical and Biophysical Research Communications·S PassarellaE Quagliariello
Dec 15, 1986·Biochemical and Biophysical Research Communications·M BarileE Quagliariello
Jan 1, 1974·Methods in Enzymology·J W Greenawalt
Jul 15, 1993·Biochemical and Biophysical Research Communications·J S Modica-Napolitano
Sep 1, 1993·Archives of Biochemistry and Biophysics·M BarileE Quagliariello

❮ Previous
Next ❯

Citations

Jan 2, 2003·Annals of Neurology·Sanjay C KeswaniAhmet Hoke
Sep 4, 1999·Journal of the Neurological Sciences·A MasiniV Vannini
Oct 29, 1998·General Pharmacology·M BarileS Passarella
Jun 5, 2003·The Lancet Infectious Diseases·Anthony Emmanuel O OgedegbeAnna Mae Diehl
Feb 9, 2006·Chemical Reviews·Maria A GraziewiczWilliam C Copeland
Jul 21, 2000·European Journal of Biochemistry·M BarileS Passarella
May 2, 2007·Antimicrobial Agents and Chemotherapy·Kaleb C LundKendall B Wallace
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·X R Pan-ZhouV M Darley-Usmar
Jun 7, 2014·PloS One·Andrzej M Woyda-Ploszczyca, Wieslawa Jarmuszkiewicz
Sep 7, 2011·Drug Metabolism Reviews·Dominique PessayreAbdellah Mansouri
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·George P H Leung, Chung-Ming Tse
Nov 20, 2009·Scandinavian Journal of Infectious Diseases·Anne Maagaard, Dag Kvale
Feb 27, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Anissa IgoudjilBernard Fromenty
Dec 18, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A CossarizzaA Viganò
Jun 20, 2006·Biochimica Et Biophysica Acta·Marcello PintiAndrea Cossarizza
May 24, 2005·Biochemical Pharmacology·Nathalie Dias, Christian Bailly
Sep 7, 2018·Journal of Cellular Biochemistry·Jessy J FadelKarim S Echtay
Oct 4, 2003·Nature Reviews. Drug Discovery·William LewisWilliam C Copeland
Jul 11, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Leshern KaramchandAnil A Chuturgoon
May 7, 2020·European Journal of Nutrition·Apiwan ArinnoNipon Chattipakorn
Sep 20, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Zoltán V VargaPál Pacher
Nov 1, 2002·AIDS·Sanjay C KeswaniJustin C McArthur
Jun 15, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·W LewisB J Day
Aug 3, 2005·The Biochemical Journal·Patrick C BradshawDavid C Samuels
Jan 13, 2006·Mitochondrion·Karima BegricheBernard Fromenty
Jun 30, 2004·Diabetes & Metabolism·B FromentyD Pessayre
Mar 7, 2007·Medicina clínica·Erika Santos Corraliza, Aurelio Fuertes Martín

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.